Assurance Healthcare Limited (RCU) Fair Value & Analysis
Technology · SG · Market cap 16.1M SGD
Fair value as of: Jul 4, 2026
From 3 valuation models · updated today
Share price +45.2% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.0300 SGD – 0.0750 SGD · the 0.0610 SGD price screens above the 0.0299 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Assurance Healthcare Limited (RCU) currently trades at 0.0610 SGD, while our model-based Fair Value estimate is 0.0299 SGD — implying the stock looks roughly 51.0% overvalued today. We read business quality at 45/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Assurance Healthcare Limited generated revenue of 740K SGD at a net margin of -98.9%. Revenue grew 60.0% year over year. It earns a return on equity of -11.9%. Fundamentals as of Jul 4, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Assurance Healthcare Limited, an investment holding company, operates in the healthcare business in Singapore. The company develops and distributes healthcare products and services and manages healthcare solutions through retail, direct selling, network marketing, and e-commerce. It offers managed healthcare solutions to corporations through a network of medical service providers to deliver healthcare services to the employees of corporations. It also offers various services, including real-time information and cost control; work injury case management; online employment medical check-up reports; and vaccination and infectious disease testing services. The company was formerly known as Revez Corporation Ltd. and changed its name to Assurance Healthcare Limited in August 2024. The company is based in Singapore.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Assurance Healthcare Limited reported revenue of 740K SGD in FY2025 versus 7.5M SGD in FY2021, a compound −44.0%/yr. Reported net income was −732K SGD in FY2025.
Is RCU fairly valued? → Check now
Similar stocks
6 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| International Business Machines Corporation IBM | $252.22 | $147.06 | -42% |
| Accenture plc ACN | $170.50 | $228.49 | +34% |
| Tata Consultancy Services Limited TCS | ₹2,199 | ₹1,863 | -15% |
| Infosys Limited INFY | ₹1,198 | ₹1,237 | +3% |
| HCL Technologies Limited HCLTECH | ₹1,132 | ₹1,230 | +9% |
| Fiserv, Inc F1IS34 | R$122.88 | R$56.23 | -54% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Assurance Healthcare Limited (RCU) undervalued?
What is the fair value of RCU?
What is the quality score of RCU?
What is the revenue of Assurance Healthcare Limited (RCU)?
What is the net profit margin of RCU?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.